Literature DB >> 1333487

Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin.

A L Barry1, J H Jorgensen, D J Hardy, S D Allen, C N Baker, P C Fuchs, J C McLaughlin.   

Abstract

Haemophilus influenzae isolates were uniformly susceptible to enoxacin, ofloxacin, and temafloxacin. Zone diameter and MIC interpretive criteria were proposed to define susceptible populations so that mutants with diminished susceptibility might be detected when and if they appear in clinical specimens. Additional collaborative quality control studies defined MIC and zone size limits for tests with H. influenzae ATCC 49247.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1333487      PMCID： PMC270573          DOI： 10.1128/jcm.30.11.3013-3015.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacin.

Authors:  A L Barry; M A Cohen; J C Sesnie; P C Fuchs; J A Washington; P R Murray; C Baker
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

2.  Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing Group.

Authors:  A L Barry; P C Fuchs; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1989 Sep-Oct       Impact factor: 2.803

3.  Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.

Authors:  T L Gavan; R N Jones; A L Barry; P C Fuchs; E H Gerlach; J M Matsen; L B Reller; C Thornsberry; L D Thrupp
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

4.  Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin.

Authors:  P C Fuchs; A L Barry; C Baker; P R Murray; J A Washington
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

5.  Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.

Authors:  J H Jorgensen; J S Redding; L A Maher; A W Howell
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

6.  Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain.

Authors:  J H Jorgensen; A L Barry; G V Doern; M J Ferraro; P R Murray
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

7.  Haemophilus influenzae ATCC 49766, an alternative quality control strain for monitoring broth microdilution susceptibility tests with selected beta-lactams.

Authors:  A L Barry; J H Jorgensen; D J Hardy; S D Allen; C N Baker
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948
  7 in total
  3 in total

1.  Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters.

Authors:  A L Barry; P C Fuchs; S D Allen; J H Jorgensen; F C Tenover; P R Murray; D J Hardy; C N Baker
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

2.  Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.

Authors:  María Pérez-Vázquez; Federico Román; Belén Aracil; Rafael Cantón; José Campos
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

3.  Ramoplanin susceptibility testing criteria.

Authors:  A L Barry; M A Pfaller; P C Fuchs
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.